Variation in US private health plans' coverage of orphan drugs.

CONCLUSIONS: Health plans restrict access to orphan drugs approximately one-third of the time, and restrictions vary considerably across plans. Plans more often add restrictions for orphan drugs that are indicated for diseases with a higher prevalence and that have higher annual costs.
PMID: 31622066 [PubMed - in process]

Source: The American Journal of Managed Care - September 30, 2019 Category: Health Management Authors: Chambers JD, Panzer AD, Kim DD, Margaretos NM, Neumann PJ Tags: Am J Manag Care Source Type: research